SI1509517T1 - Nova sinteza irbesartana - Google Patents

Nova sinteza irbesartana

Info

Publication number
SI1509517T1
SI1509517T1 SI200430833T SI200430833T SI1509517T1 SI 1509517 T1 SI1509517 T1 SI 1509517T1 SI 200430833 T SI200430833 T SI 200430833T SI 200430833 T SI200430833 T SI 200430833T SI 1509517 T1 SI1509517 T1 SI 1509517T1
Authority
SI
Slovenia
Prior art keywords
irbesartan
novel synthesis
synthesis
novel
provides
Prior art date
Application number
SI200430833T
Other languages
English (en)
Inventor
Gennady Nisnevich
Igor Rukhman
Boris Pertsikov
Julia Kaftanov
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of SI1509517T1 publication Critical patent/SI1509517T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
SI200430833T 2003-01-16 2004-01-16 Nova sinteza irbesartana SI1509517T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44099703P 2003-01-16 2003-01-16
EP04702955A EP1509517B1 (en) 2003-01-16 2004-01-16 Novel synthesis of irbesartan
PCT/US2004/001135 WO2004065383A2 (en) 2003-01-16 2004-01-16 Novel synthesis of irbesartan

Publications (1)

Publication Number Publication Date
SI1509517T1 true SI1509517T1 (sl) 2008-10-31

Family

ID=32771889

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430833T SI1509517T1 (sl) 2003-01-16 2004-01-16 Nova sinteza irbesartana

Country Status (10)

Country Link
US (6) US7019148B2 (sl)
EP (3) EP2189457A1 (sl)
CN (2) CN1759113A (sl)
AT (1) ATE398121T1 (sl)
CA (1) CA2513373A1 (sl)
DE (1) DE602004014321D1 (sl)
ES (1) ES2281312T3 (sl)
PT (1) PT1509517E (sl)
SI (1) SI1509517T1 (sl)
WO (1) WO2004065383A2 (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7941149B2 (en) 2002-05-13 2011-05-10 Misonimo Chi Acquistion L.L.C. Multi-hop ultra wide band wireless network communication
US7957356B2 (en) * 2002-05-13 2011-06-07 Misomino Chi Acquisitions L.L.C. Scalable media access control for multi-hop high bandwidth communications
US8780770B2 (en) * 2002-05-13 2014-07-15 Misonimo Chi Acquisition L.L.C. Systems and methods for voice and video communication over a wireless network
EP2189457A1 (en) * 2003-01-16 2010-05-26 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
CA2640585A1 (en) 2003-02-05 2004-08-26 Teva Pharmaceutical Industries Ltd. Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one
US20090286990A1 (en) * 2004-05-20 2009-11-19 Reguri Buchi Reddy Process for preparing irbesartan
TWI346108B (en) * 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
DE102004060699A1 (de) * 2004-12-16 2006-06-22 Ratiopharm Gmbh Verfahren zur Herstellung von Candesartan
ES2308591T3 (es) * 2004-12-22 2008-12-01 Algry Quimica, S.L Intermedios para la preparacion de antagonistas de los receptores de la angiotensina ii.
SI21965A (sl) * 2005-01-05 2006-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava tetrazolskega derivata
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
US20090176849A1 (en) * 2005-05-24 2009-07-09 Lek Pharmaceuticals, D.D. Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl) Methyl)-imidazole, dihydroimidazole or benzimidazloe derivatives
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
EP1764365A1 (en) 2005-09-20 2007-03-21 KRKA, D.D., Novo Mesto A process for the preparation of sartan derivates and intermediates useful in such process
EP1948641A1 (en) 2005-10-28 2008-07-30 Alembic Limited An improved process for preparation of irbesartan
ES2300175B1 (es) * 2006-02-14 2009-06-08 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
ES2371910T3 (es) 2006-04-07 2012-01-11 Lek Pharmaceuticals D.D. Procedimiento para la preparación de irbesartán puro.
US8175613B2 (en) 2006-08-04 2012-05-08 Misonimo Chi Acquisitions L.L.C. Systems and methods for determining location of devices within a wireless network
WO2008027385A2 (en) * 2006-08-29 2008-03-06 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole
KR101102719B1 (ko) * 2006-12-07 2012-01-05 미소니모 카이 액퀴지션 엘엘씨 타임슬롯 및 채널 할당을 위한 시스템 및 방법
WO2010126013A1 (ja) 2009-04-28 2010-11-04 第一三共株式会社 オルメサルタンメドキソミルの製造方法
CN106608886A (zh) * 2015-11-22 2017-05-03 宁夏际华环境安全科技有限公司 一种苯基硼酸生产工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US531929A (en) * 1895-01-01 harden
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5270317A (en) 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
AU2494792A (en) * 1991-08-19 1993-03-16 E.I. Du Pont De Nemours And Company Angiotensin ii receptor blocking imidazolinone derivatives
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
EP0669830A4 (en) * 1992-11-06 1997-02-26 Merck & Co Inc SUBSTITUTED DIPEPTIDE ANALOGS PROMOTING THE RELEASE OF GROWTH HORMONE.
US5541209A (en) * 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
ES2129850T3 (es) * 1994-09-20 1999-06-16 Wakunaga Seiyaku Kk Procedimiento de produccion de un derivado de n-bifenilmetiltiadiazolina o una sal de este y su producto intermediario de produccion.
FR2725987B1 (fr) 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
ATE340793T1 (de) 2002-07-16 2006-10-15 Teva Pharma Neue synthese von irbesartan
EP2189457A1 (en) * 2003-01-16 2010-05-26 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan

Also Published As

Publication number Publication date
EP1509517B1 (en) 2008-06-11
ES2281312T1 (es) 2007-10-01
US7217825B2 (en) 2007-05-15
DE602004014321D1 (de) 2008-07-24
US7301035B2 (en) 2007-11-27
ES2281312T3 (es) 2008-08-01
PT1509517E (pt) 2008-08-05
EP2039693A2 (en) 2009-03-25
EP1509517A2 (en) 2005-03-02
US20060128968A1 (en) 2006-06-15
CN101165062A (zh) 2008-04-23
US20060135544A1 (en) 2006-06-22
US7227026B2 (en) 2007-06-05
WO2004065383A3 (en) 2004-12-16
US20040192713A1 (en) 2004-09-30
WO2004065383A2 (en) 2004-08-05
US20060135780A1 (en) 2006-06-22
US20070213539A1 (en) 2007-09-13
CA2513373A1 (en) 2004-08-05
EP2039693A3 (en) 2009-06-17
US7838683B2 (en) 2010-11-23
US20090216026A1 (en) 2009-08-27
CN1759113A (zh) 2006-04-12
US7019148B2 (en) 2006-03-28
EP2189457A1 (en) 2010-05-26
ATE398121T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
SI1509517T1 (sl) Nova sinteza irbesartana
HK1157334A1 (en) Process for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3- benzazepine hydrochloride hemihydrate (r)-8--1--2345--1h-3-
ZA200307450B (en) Process for the production of synthesis gas.
IL175390A0 (en) Parocess for the preparation of telmisartan
HK1145322A1 (sl)
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
PT1592793E (pt) Compostos oligoméricos para a modulação da expressão de survivina
IL175253A0 (en) A process for preparing pyrrole derivatives
HRP20050360A2 (en) Novel method for the industrial synthesis of the m
MXPA03006322A (es) Procedimiento mejorado para la sintesis de carbapenem.
TW200637832A (en) Process for preparing amorphous valsartan
PL1680430T3 (pl) Sposoby wytwarzania postaci i (s)-(+)-wodorosiarczanu klopidogrelu
ZA200602149B (en) Process for the synthesis of 6-amino-4-[(3-chloro-4-fluo-rophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
MXPA03004986A (es) Proceso para preparar polimeros de emulsion con alta pureza.
TW200510376A (en) Process for preparing (s)-pantoprazole
EP1598389A4 (en) METHOD FOR PRODUCING A CATIONICALLY HARDENABLE SILICONE COMPOUND
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
TWI319707B (en) Method of purifying pravastatin
AU2003303563A1 (en) Process for synthesizing amine from nitrile
AU2003302339A1 (en) Process for synthesizing amine from nitrile
MXPA05009152A (es) Preparacion de k-252a.
TW200420553A (en) Process for the synthesis of 3, 3a, 6, 6a-tetrahydro-2H-cyclopentan[b]furan-2-one
TW200745060A (en) Novel process
MXPA05012838A (es) Procedimiento mejorado.